Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Julphar
Accenture
Teva
Harvard Business School

Generated: July 19, 2019

DrugPatentWatch Database Preview

Patent: 8,476,225

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,476,225
Title:Antiviral compounds
Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Inventor(s): Casarez; Anthony (Princeton, NJ), Ji; Mingzhe (Union City, CA), Kim; Choung U. (San Carlos, CA), Sheng; Xiaoning C. (Foster City, CA), Wu; Qiaoyin (Foster City, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:12/958,086
Patent Claims:see list of patent claims

Details for Patent 8,476,225

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Hoffman-la Roche PEGASYS peginterferon alfa-2a SYRINGE 103964 002 2002-10-16 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a VIAL; SUBCUTANEOUS 103964 001 2002-10-16 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
US Department of Justice
US Army
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.